Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Alterity and UniQuest partner to reverse bacterial resistance to antibiotics
2020-12-22 05:42
Alterity announces approval of US patent for next generation compounds to treat neurodegenerative diseases
2020-11-17 01:09
Alterity announces approval of US patent for next generation compounds to treat neurodegenerative diseases
2020-11-16 21:42
Alterity commences enrolling Multiple System Atrophy patients in bioMUSE Study
2020-10-27 10:03
New data independently confirms and extends laboratory findings and expands safety profile of ATH434
2020-08-04 09:33
Alterity Releases Appendix 4C - Q4 FY20 Quarterly Cash Flow Report
2020-07-31 06:49
Alterity Therapeutics meeting with US FDA provides development pathway for ATH434
2020-06-30 11:14
Alterity Therapeutics presents data on ATH434 to the American Academy of Neurology
2020-05-21 08:58
Alterity Therapeutics Limited Releases Its Appendix 4C - Q3 FY20 Quarterly Cash Flow Report
2020-04-30 16:35
Alterity Receives Non-Compliance Notice Regarding NASDAQ Minimum Bid Price Requirement
2020-02-07 21:00
1
2
3